<ѻý>FDA Broadens Options for Relapsed/Refractory Multiple Myeloma With Teclistamabѻý> Bispecific antibody achieved durable responses in a majority of heavily pretreated patients Oct 25, 2022
<ѻý>Sexual Health Not Part of Discussion for Women Undergoing Brachytherapyѻý> Much less likely than men to be queried about sexual function when receiving treatment Oct 25, 2022
<ѻý>Shorter Course of Radiation Therapy Proves Mettle in High-Risk Prostate Cancerѻý> Hypofractionation matches standard RT for survival and toxicity in a third less time Oct 25, 2022
<ѻý>Low Rates of PSA Screening Linked to Increase in Metastatic Prostate Cancerѻý> Will USPSTF's 2018 guidelines reverse this trend? Oct 25, 2022
<ѻý>New Standard-of-Care Therapy for Advanced Liver Cancerѻý> Stereotactic body radiotherapy plus sorafenib improves survival versus targeted drug alone Oct 24, 2022
<ѻý>Nerve-Freezing Technique Staves Off Post-Mastectomy Painѻý> Percutaneous cryoneurolysis improved analgesia in a pilot study Oct 24, 2022
<ѻý>Rapid Radiotherapy Technique Shows Promise in First Human Trialѻý> FLASH relieved pain in most patients with bone metastases, with few side effects Oct 24, 2022
<ѻý>High-Dose-Rate Brachytherapy Boost in Prostate Cancer Improves QOLѻý> Patients report better urinary and bowel function outcomes Oct 24, 2022
<ѻý>FDA Approves New CTLA-4 Inhibitor for Cancer Treatmentѻý> Tremelimumab (Imjudo), in combination with durvalumab, lands approval in advanced liver cancer Oct 24, 2022
<ѻý>Is Your Oven Leaking Cancer-Causing Chemicals Into Your Kitchen?ѻý> Study finds that natural gas leaks result in elevated benzene levels, even when stove not in use Oct 20, 2022
<ѻý>Should We Still Be Concerned About Cell Phones and Brain Cancer?ѻý> Experts weigh in on why the topic has seemed to lose steam in recent years Oct 20, 2022
<ѻý>Mepitel Film Beats Standard for Stopping Radiation Dermatitis in Breast Cancerѻý> "The most improvement in skin toxicity that I have seen in many years," expert says Oct 19, 2022
<ѻý>Risk of Secondary Breast Cancer After Childhood Cancer Is Declining, Study Suggestsѻý> Improvement credited to changes in chest RT, attenuated by use of pelvic RT, anthracyclines Oct 13, 2022
<ѻý>This One Risk Factor Dominates for Soft Tissue Sarcoma After Breast Cancerѻý> Risk is low but appears to have modifiable components Oct 13, 2022
<ѻý>U.S. Experts Weigh In on Colonoscopy Status in Wake of European Trialѻý> Concerns abound after study suggests colonoscopy may be less effective than expected Oct 12, 2022
<ѻý>Caregiving at the Endѻý> Co-host Tyler Johnson talks with the husband of previous guest, Ellen Dunphy, who died in July Oct 11, 2022 podcast
<ѻý>Lung Cancer Screening Programs Hit the Mark on Eligibility Criteriaѻý> However, adherence to follow-up screening is "suboptimal" Oct 10, 2022
<ѻý>More Evidence Backing Anti-CDK4/6-Based Therapy in Recurrent Endometrial Cancerѻý> Abemaciclib plus letrozole led to 30% objective response rate, 55.6% PFS rate at 6 months Oct 10, 2022
<ѻý>If You Invite 455 People to Colonoscopy, You'll Stop One Case of Cancerѻý> Risk of colorectal cancer reduced with screening in randomized trial, but less than expected Oct 09, 2022
<ѻý>Katie Couric's Breast Cancerѻý> The popular media personality is on a mission to raise awareness around dense breasts Oct 06, 2022
<ѻý>FDA's Power Morcellator Warning Tied to Drop in Distant Leiomyosarcomasѻý> Local and regional illness remained unchanged Oct 04, 2022
<ѻý>Combo Therapy Shows Promise in Advanced Thymic Epithelial Tumorsѻý> "Clinically remarkable outcomes" with PD-L1 inhibitor plus anti-angiogenesis agent Oct 04, 2022
<ѻý>Pandemic Led to Surgical Delays in Gynecologic Cancers, and Worse Outcomesѻý> One in five patients experienced changes in their care plan Oct 04, 2022
<ѻý>SABR for Oligometastatic Cancer Turns in 'Acceptable' Rates of Toxicityѻý> Rates of grade 2 or higher toxicities less than those observed in landmark SABR-COMET study Oct 03, 2022
<ѻý>Adding Chemo Not Better for Recurrent Endometrial Cancerѻý> Trial suggests radiation therapy alone remains standard of care for pelvic-only recurrences Oct 03, 2022
<ѻý>Transplant With Orca-T Reduced GVHD in Hematologic Malignanciesѻý> Risk of relapse was also lower in the group who received the cell therapy Oct 03, 2022
<ѻý>Durvalumab-CRT Pairing Disappoints in Locally Advanced Cervical Cancerѻý> Still, CALLA trial findings "will inform future strategies to improve treatment," researcher says Oct 02, 2022
<ѻý>ADC Offers Promising Results in Relapsed or Refractory Hodgkin Lymphomaѻý> Good response rate with camidanlumab tesirine, although a lot of patients experienced AEs Oct 02, 2022
<ѻý>Rucaparib a Winner for PFS, But Not for OS, in Recurrent Ovarian Cancerѻý> PARP inhibitor still has value as maintenance therapy, ARIEL3 investigator says Oct 01, 2022
<ѻý>'Potential Detrimental Effect' With Fourth-Line Olaparib in Ovarian Cancerѻý> Post-hoc data from SOLO3 show diverging results based on prior lines of therapy Sep 30, 2022
<ѻý>Anti-BCMA-Based Regimen Impresses in Relapsed/Refractory Myelomaѻý> Belamaf plus lenalidomide-dexamethasone achieved encouraging responses Sep 30, 2022
<ѻý>Response-Based Ponatinib Dose Reduction a Win-Win in Chronic-Phase CML?ѻý> Strategy applied in OPTIC trial may mitigate adverse events without sacrificing benefit Sep 29, 2022
<ѻý>Magrolimab-Azacitidine Shows Promise in Untreated High-Risk MDSѻý> About a third of patients, including those with TP53 mutations, achieved complete remission Sep 29, 2022
<ѻý>Immunotherapy First for BRAF Melanoma Edges Out Targeted Combinationѻý> "Clinically meaningful" improvement in 2- and 3-year survival Sep 28, 2022
<ѻý>Was I Conned by a 'Grey's Anatomy' Writer?ѻý> Her alleged duplicity could make things tougher for female patients Sep 27, 2022
<ѻý>Cancer in Kids Tied to Prenatal Exposure to High-Dose Folic Acid and Seizure Medsѻý> But no link seen among children of mothers without epilepsy Sep 26, 2022
<ѻý>'Unparalleled Times' in Hematology, but Workforce Issues Persistѻý> "This is the most exciting time ever" to be a hematologist, says ASH President Jane Winter, MD Sep 26, 2022 video
<ѻý>What's on Tap at the Society of Hematologic Oncology's 10th Annual Meetingѻý> Emphasis on novel biological approaches in treating patients with hematologic malignancies Sep 26, 2022
<ѻý>FDA Grants First Tumor-Agnostic Approval for RET Fusion-Positive Cancersѻý> Selpercatinib approved for advanced or metastatic solid tumors that progress on systemic therapy Sep 22, 2022
<ѻý>How Does Oncology Deal With Pandemic Burnout?ѻý> Evidence suggests the pandemic could have long-term consequences Sep 20, 2022